Lymphocyte shedding from genital tract of human immunodeficiency virus-infected women: Immunophenotypic and clinical correlates

American Journal of Obstetrics and Gynecology

Volumn 176, Issue 1 I, 1997, Pages 158-165

  Bardeguez, Arlene D ^a   Skurnick, Joan H ^a   Ferez, George ^b   Colon, Jose M ^a   Kloser, Patricia ^c   Denny, Thomas N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OF NEW JERSEY   (United States)

^c ST MICHAEL S MEDICAL CENTER   (United States)

Author keywords

Genital tract; Human immunodeficiency virus infection; Lymphocytes; Mucosal immunity; Women

Indexed keywords

ADULT; ARTICLE; BLOOD; CYTOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; UTERINE CERVIX; UTERINE CERVIX MUCUS; VAGINA;

ADULT; CERVIX MUCUS; CERVIX UTERI; FEMALE; HIV SEROPOSITIVITY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; VAGINA;

EID: 0030635679     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)80029-4     Document Type: Article

References (24)

1. Update: mortality attributable to HIV infection/AIDS among persons aged 25-44 years - United States, 1990-1991. MMWR Morb Mortal Wkly Rep 1993;42:481-6.
2. Update: AIDS among women - United States, 1994. MMWR Morb Mortal Wkly Rep 1995;44:81-4.
3. Padian NS, Shiboski SC, Jewell NP. The effect of number of exposures on the risk of heterosexual HIV transmission. J Infect Dis 1990;161:883-7.
4. KreissJK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes.] Infect Dis 1989; 160:380-4.
5. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type I in semen. JAMA 1992:267: 2769-74.
6. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmis-sion of human immunodeficiency virus. JAMA 1991;266: 1064-7.
7. Vogt MW, Craven DE, Crawford DF, el ai. Isolation of HTI.V-III/LAC from cervical secretions of women at risk of AIDS. Lancet 1986; 1:525-7.
8. Wofsy CB, Hauer LB, Michaelis RA, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; 1:527-9.
9. Clemetson DBA, Moss OB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA 1993:239:2860-4.
10. Levy JA. The transmission of AIDS: the case of the infected cell! JAMA 1988;259:3037-8.
11. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994;170: 1597-601.
12. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier I.. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnancy HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:72-5.
13. Pomerantz RJ, De la Monte SM, Donegan SP, et al. HIV infection of the uterine cervix. .Ann Intern Med 1988;108: 321-7.
14. Philip DM. The role of cell-to-cell transmission in HIV infection. AIDS 1994;8:719-31.
15. Denny TN, Skurnick JH, Garcia A, et al. Lymphocyte immunoregulatory cells present in semen from HIV-infected individuals: a report from the HIV heterosexual transmission study. Comm Clin Cytom 1996;26:47-51.
16. Hill JA, Anderson DJ. Human vaginal leukocytes and elfecls of vaginal fluid on lymphocyte and macrophage defense functions. Am J Obstet Gynecol 1992; 166:720-6.
17. Calvflli T, Denny TN, Paxton H, Gelman R, Kagan JM. Guidelines for flow cytometry immnnophenotyping: a report from the National Institute of Allergy and Infections Disease/Division of AIDS. J Cytom 1993; 14:702-15.
18. AIDS Clinical Trial Group. Virology manual for laboratories. Bethesda (MD): National Institute of Allergy and Infectious Diseases, Division of AIDS, 1993.
19. Vogt MW, Witt D|, Craven DE, et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106:380-2.
20. 8+ cells. J Immunol 1991;146: 2220-6.
21. Sanders ME, Makgoba WM, Shaw S. Human naive and memory T cells reinterpretation of helper-inducer and supprcssor-inducer subsets. Immunol Today 1988;9:195-9.
22. I.ebner T, Bergmeier LA, Panagiotidi C, et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992;258:1365-9.
23. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, et al. Protection against vaginal HIV transmission with microencapsulated vaccine. Science 1993;260: 1323-7.
24. Elias CJ, Heise L. The development of microbicides: a new method of HIV prevention for women. New York: Population Council, 1993.